Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. - Wikidata - wikimedia - TriplyDB

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

http://www.wikidata.org/entity/Q33881297

about

Benralizumab: a unique IL-5 inhibitor for severe asthma Eosinophilia in Hematologic Disorders Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders Dramatic and early response to low-dose steroid in the treatment of acute eosinophilic myocarditis: a case report.Expression profiling of differentiating eosinophils in bone marrow cultures predicts functional links between microRNAs and their target mRNAs.Hypereosinophilic Syndrome With Eosinophilic Gastritis.A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia Idiopathic hypereosinophilic syndrome with 20 years of diagnostic delay Novel targeted therapies for eosinophil-associated diseases and allergy The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.Hypereosinophilic Syndrome.IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells Eosinophils: changing perspectives in health and disease.Renal involvement in idiopathic hypereosinophic syndrome.Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.Circulating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders.Therapeutic approaches to patients with hypereosinophilic syndromes.A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report How I treat hypereosinophilic syndromes.The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.ICON: Eosinophil Disorders Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.A Case of Erythroderma Secondary to Hypereosinophilia.Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia.Atypical Presentation of Intracardiac Floating Thrombi in Hypereosinophilic Syndrome Complicated With Stroke and Systemic Embolization: A Case Report.CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: A case report and literature review.Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.Rapid Change in Mental Status in a Patient with Hypereosinophilia.Marked and persistent eosinophilia in the absence of clinical manifestations.Idiopathic eosinophilic pneumonia in children: the French experience.World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.Targeting eosinophils in allergy, inflammation and beyond.Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.

P2860

Q26750711-0375AEE8-9E7D-4313-8BF4-FF8AA25B0E45 Q26799611-3D9DB535-EE70-4CB1-9E1D-C8CA2D44B41C Q27003331-ACA9E350-5874-49FE-864D-C965D5769EDE Q28307714-493FB787-2E72-47AC-8E12-2962FB3AACF4 Q29994762-39FADB93-1567-400E-927B-4D69561F144C Q33604866-9E36309A-DB03-4F6F-8CE2-56CA4789D34D Q33606709-594FF9CF-DBBC-4F17-807C-1E0F6179039B Q33716750-8F2B6F26-4F68-41B5-A04A-66AF2675D4E9 Q33758956-2D8A5D1C-2D43-40E7-8B03-D3159AF4913A Q34444620-F15ED2D2-DD89-4D6D-BDE6-F17C63B02D5D Q34447936-B2EB4350-E21E-41A2-B7BA-2D94455ABE63 Q34465853-1C1A6013-FA83-4DDC-A637-4C603C56CE78 Q34498306-6E92591C-5E39-4FC9-A04B-22E0D8E10729 Q34547831-65904213-1455-43F1-A490-D17957D36771 Q34624093-C775141F-779C-4712-8020-A3E3112A6BD0 Q34786462-853E838A-2285-4563-ACA0-2F6B2DCD5920 Q35170969-7C0E604F-3FFA-4177-9026-AA827068F9E4 Q35452456-85A55101-47E5-4B6C-9B78-98FCBA575EC7 Q35569801-02BCFA0B-386F-44E9-934C-370962564DC7 Q35829354-35BD3483-44CF-4681-872B-7F1BE3EBCA4E Q35857340-F11A1D4D-B8B1-4F9B-A203-3A0100A57FCA Q35904389-18D2D864-E172-4E87-8164-3626ECC01122 Q36000858-57010FE0-86CC-463B-A29D-D0B3341C0F7E Q36008991-2EA77254-6DD5-4543-ABF9-1B6BC2DD7173 Q36573038-FA9685B6-15A6-48D0-AF35-C7F50AC072E5 Q36834826-BD06706E-E2F8-4644-ABC4-A7BB43AFABE3 Q36859237-C0B4234A-81F1-46C4-A06C-C43BAAA38196 Q37059851-91D470CE-0150-45DE-8D9A-D5B1A72955EA Q37102781-586E2F09-DC3D-4E70-A956-B2F747BC3C14 Q37114655-5DA6CCF9-4764-4091-AD76-8F44AC3F3E77 Q37176262-3CCCF40D-7B53-4CF8-B32E-B59D991E22F9 Q37216376-CA90B6C4-72A1-412C-9DB3-19A40CB3DE51 Q37226282-0370F710-F7EF-4B74-A08C-857D0FAF16C1 Q37471625-152DD684-67D2-4528-9433-676B60CA256D Q37601849-4CA1A729-6DCC-4A8F-8C33-E26103CF14CC Q37605322-B2221D95-8048-4FA5-BED1-040CECC4AB5D Q37608220-E9D59256-1458-4677-8E22-7A64C0603B45 Q38038509-BE103FA2-E313-4D5A-A48B-7DDFAB930925 Q38075409-7A17AABB-0D1E-48B6-BF68-F2BEB4D17F88 Q38131481-0DBE29A1-A86A-4D7F-9AF4-B01772EF2A1F

P2860

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

http://www.wikidata.org/entity/Q33881297

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Contemporary consensus proposa ...... sorders and related syndromes.

@ast

Contemporary consensus proposa ...... sorders and related syndromes.

@en

type

label

Contemporary consensus proposa ...... sorders and related syndromes.

@ast

Contemporary consensus proposa ...... sorders and related syndromes.

@en

prefLabel

Contemporary consensus proposa ...... sorders and related syndromes.

@ast

Contemporary consensus proposa ...... sorders and related syndromes.

@en

P1433

Q33881297-4CCD100D-6370-4262-9F52-9635A81D1D0F

P1476

Q33881297-0C3E1D13-5D8E-41CE-BDDB-BA97EFD5409F

P2093

Q33881297-26519EAE-9848-452D-892B-023FB84DFC64

Q33881297-38F4156A-C599-4EA7-B213-A49FFE7112CE

Q33881297-4345DA6A-7848-4950-87AE-E0D57157C2F0

Q33881297-7151B7C2-125F-4FED-86D9-7A7B6236C84F

Q33881297-928075A7-836B-45B4-96B7-0B85CED404CB

Q33881297-971FC786-F229-4A42-8748-D8BD99D262B4

Q33881297-BA17D609-7BC2-4550-BF99-5CD74458BAE9

Q33881297-CA44885B-6DEF-433B-B42F-3889EFDCFD0C

Q33881297-D9AE8BEF-CFD0-4050-B32E-D56F905AD697

Q33881297-DC469F1F-2D48-4B99-8E97-6F69763DA5A3

P2860

Q33881297-049C4C18-2519-4D36-A023-9DC10DABBFF7

Q33881297-0A8A848A-44E4-4063-86A7-84BFBEFD2918

Q33881297-15CEB5DA-377B-4F84-9C7C-A0D095E19953

Q33881297-22DEC54A-13C4-4C38-9EB3-3135F4F01966

Q33881297-29987641-2A20-4DD6-A40F-3A2CEF5B6B39

Q33881297-2C400779-28E4-43A8-A21C-2362BFECBBA9

Q33881297-326A8898-C92C-4770-AABD-A796033AF14C

Q33881297-3E72097C-FA9E-4C73-8F48-CEE4222CE494

Q33881297-570287A0-6116-4065-91CE-9F61D76E78DE

Q33881297-79BF4E1B-49DE-4025-831A-0F683948BACC

P304

Q33881297-816967D5-8BB8-47C8-A62F-55ECF3524762

P31

Q33881297-4027F3A6-8B9B-493B-8F02-755AA04971F9

P356

Q33881297-13901146-FCFB-4BE8-9361-B26407956E5E

P407

Q33881297-4BECD8A6-21A8-450E-8DFF-112E201E9D7B

P433

Q33881297-95071906-4747-4FE5-A5BC-BC6C74527FF5

P478

Q33881297-B86E6A4E-D3D5-456E-9B7B-A4019F05BF48

P50

Q33881297-230D03C0-9D9D-47F5-8963-9F42808A594D

Q33881297-44D09346-5B2D-4190-A3C9-F6F345EAAC49

Q33881297-6100248F-38E6-414E-9AE3-CFD7A5BCC074

Q33881297-A6B0D862-D584-430B-A043-96F2EA8B6B11

Q33881297-ECB72D60-76C7-473E-A8CF-22AC18CEC365

P577

Q33881297-73141425-8E63-4989-9EDF-4A4A7921FB5B

P698

Q33881297-BE799BC9-196E-4A71-947F-92C67F3ABC05

P932

Q33881297-75942C16-1777-4825-A120-3F3FBA72AA23

P356

J.JACI.2012.02.019

P1433

The Journal of Allergy and Clinical Immunology

P1476

Contemporary consensus proposa ...... sorders and related syndromes.

@en

P2093

Andreas Reiter

http://www.w3.org/2001/XMLSchema#string

Andrzej Hellmann

http://www.w3.org/2001/XMLSchema#string

Florence Roufosse

http://www.w3.org/2001/XMLSchema#string

Gerald J Gleich

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Horny

http://www.w3.org/2001/XMLSchema#string

Jason Gotlib

http://www.w3.org/2001/XMLSchema#string

Joseph H Butterfield

http://www.w3.org/2001/XMLSchema#string

Karl Sotlar

http://www.w3.org/2001/XMLSchema#string

Kristin M Leiferman

http://www.w3.org/2001/XMLSchema#string

Michel Arock

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of eosinophil-associated inflammation.

Familial eosinophilia: a benign disorder?

Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.

Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis.

Refining the definition of hypereosinophilic syndrome.

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

The hypereosinophilic syndromes: still more heterogeneity.

Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.

Eosinophilia: secondary, clonal and idiopathic.

Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.

P304

607-612.e9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2012.02.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Peter Vandenberghe

Torsten Haferlach

Georgia Metzgeroth

P577

2012-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22460074

http://www.w3.org/2001/XMLSchema#string

P932

4091810

http://www.w3.org/2001/XMLSchema#string